Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Express Pharma
Entering pharma drug discovery presents an opportunity to apply scientific capabilities to a new set of health challenges
Godavari Biorefineries is advancing research into novel cancer therapies, securing US patent protection and expanding the geographical reach of its intellectual property following earlier grants in India, China and Japan. Dr Sangeeta Srivastava, Executive Director, Godavari Biorefineries, discusses the research outcomes, therapeutic potential and significance of this milestone. The post Entering pharma drug discovery presents an opportunity to apply scientific capabilities to a new set of health challenges appeared first on Express Pharma.
Read Full Article
Express Pharma
Biocon secures Yesintek biosimilar rights in nine markets
The agreement with Janssen Sciences Ireland enables commercialisation of the proposed Stelara biosimilar in Australia, Brazil, China, Hong Kong, Israel, Mexico, New Zealand, South Korea and Kazakhstan The post Biocon secures Yesintek biosimilar rights in nine markets appeared first on Express Pharma.
Read Full Article
Pharma Tech
ESMO26: GSKās Mo-Rez seeks an edge in a crowded ADC field in ovarian cancer
GSKās Mo-Rez is projected to reach global annual sales of $540m by 2032 based on GlobalDataās analyst consensus forecast.
Read Full Article
Pharma Tech
ESMO26: Oral cell cycle inhibitors place Cyclin E1 as new target in PROC
Data for the two PROC candidates that act on Cyclin E1 were presented at ESMO26.
Read Full Article
Express Pharma
Government sets up panel to review pharma marketing rules
Three-member committee to assess whether existing safeguards against unethical marketing are effective and recommend changes to improve monitoring and enforcement. The post Government sets up panel to review pharma marketing rules appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Oct 26, 2026, 6:48 AM
Takeda to seek Japan approval for gastric cancer drug next year
The drug, arcotatug tavatecan, or TAK-921, met both those main goals of the trial in patients with advanced gastric or gastroesophageal junction cancer who had received at least two prior therapies.
PharmaShots
Oct 26, 2026, 6:45 AM
Novartis Reports P-III (NATALEE) Trial Data of Kisqali (Ribociclib) + ET Showing Overall Survival Benefit in HR+/HER2- Early Breast Cancer at ESMO 2026
Shots: Novartis has reported 6-yr follow-up data from the P-III (NATALEE) trial of Kisqali (ribociclib) + ET vs ET alone in 5,101 pts with stage II & III HR+/HER2- eBC at high risk of recurrence, incl. high-risk N0 disease, as a late-breaker at ESMO 2026 Kisqali + ET reduced the risk of death by 19.1%ā¦ The post Novartis Reports P-III (NATALEE) Trial Data of Kisqali (Ribociclib) + ET Showing Overall Survival Benefit in HR+/HER2- Early Breast Cancer at ESMO 2026 appeared first on PharmaShots.
PharmaShots
Oct 26, 2026, 6:03 AM
Johnson & Johnson Receives the ECās Approval for Tecvayli (Teclistamab) Monotherapy to Treat R/R Multiple Myeloma from First Relapse
Shots: The EC has approved Johnson & Johnsonās Tecvayli (teclistamab; BCMAxCD3 bispecific) monotherapy for adults with RRMM who have received ā„1 prior therapy, replacing its current monotherapy indication & adding monthly dosing from mos 7 (or as early as mos 3) Approval was based on the P-III (MajesTEC-9) trial vs PVd or Kd in ptsā¦ The post Johnson & Johnson Receives the ECās Approval for Tecvayli (Teclistamab) Monotherapy to Treat R/R Multiple Myeloma from First Relapse appeared first on PharmaShots.
Express Pharma
Oct 26, 2026, 5:47 AM
Entering pharma drug discovery presents an opportunity to apply scientific capabilities to a new set of health challenges
Godavari Biorefineries is advancing research into novel cancer therapies, securing US patent protection and expanding the geographical reach of its intellectual property following earlier grants in India, China and Japan. Dr Sangeeta Srivastava, Executive Director, Godavari Biorefineries, discusses the research outcomes, therapeutic potential and significance of this milestone. The post Entering pharma drug discovery presents an opportunity to apply scientific capabilities to a new set of health challenges appeared first on Express Pharma.
PharmaShots
Oct 26, 2026, 5:38 AM
Amgen and AstraZeneca Report P-III (DeLLphi-305) Trial Data of Imdelltra (Tarlatamab) + Imfinzi as 1L Maintenance Treatment for ES-SCLC at ESMO 2026
Shots: Amgen & AstraZeneca reported interim P-III (DeLLphi-305) data of Imdelltra (tarlatamab) + Imfinzi (durvalumab) vs Imfinzi alone as 1L maintenance in pts (n=563) with ES-SCLC who had not progressed after Imfinzi + Pt-based CT & etoposide; presented at ESMO 2026 Presidential Symposium & published in NEJM Combination reduced risk of death by 58% (HR=0.42)ā¦ The post Amgen and AstraZeneca Report P-III (DeLLphi-305) Trial Data of Imdelltra (Tarlatamab) + Imfinzi as 1L Maintenance Treatment for ES-SCLC at ESMO 2026 appeared first on PharmaShots.
Express Pharma
Oct 26, 2026, 5:31 AM
Biocon secures Yesintek biosimilar rights in nine markets
The agreement with Janssen Sciences Ireland enables commercialisation of the proposed Stelara biosimilar in Australia, Brazil, China, Hong Kong, Israel, Mexico, New Zealand, South Korea and Kazakhstan The post Biocon secures Yesintek biosimilar rights in nine markets appeared first on Express Pharma.
News
Latest industry coverage
Google News
Oct 26, 2026, 7:00 AM
PODTECH completes prefab modular biopharma manufacturing facility for Mubadala Bio's Bioventure Healthcare - Manufacturing Chemist
PODTECH completes prefab modular biopharma manufacturing facility for Mubadala Bio's Bioventure HealthcareĀ Ā Manufacturing Chemist
Google News
Oct 26, 2026, 6:50 AM
More tubes, more choice: Recipharm expands sterile creams and ointments - Manufacturing Chemist
More tubes, more choice: Recipharm expands sterile creams and ointmentsĀ Ā Manufacturing Chemist
Google News
Oct 26, 2026, 6:30 AM
LAST WEEK IN REVIEW - NAVLIN DAILY
LAST WEEK IN REVIEWĀ Ā NAVLIN DAILY
Google News
Oct 26, 2026, 6:10 AM
Science that competes: preparing Europeās biotech ecosystem for global leadership - The Parliament Magazine
Science that competes: preparing Europeās biotech ecosystem for global leadershipĀ Ā The Parliament Magazine
Google News
Oct 26, 2026, 6:07 AM
Egyptās Abu Al-Naga family brings in North Africa investor RMBV for 50% of ATCO Pharma in reported $50 million deal - Business Insider Africa
Egyptās Abu Al-Naga family brings in North Africa investor RMBV for 50% of ATCO Pharma in reported $50 million dealĀ Ā Business Insider Africa
Google News
Oct 26, 2026, 5:53 AM
Canaf Therapeutics Focuses on Global Technology Transfer and Clinical Data, Aiming to Overcome Weaknesses - ėØøėķ¬ė°ģ“
Canaf Therapeutics Focuses on Global Technology Transfer and Clinical Data, Aiming to Overcome WeaknessesĀ Ā ėØøėķ¬ė°ģ“
Google News
Oct 26, 2026, 5:12 AM
Biotech manufacturing facility opens in Brisbane - Lab + Life Scientist
Biotech manufacturing facility opens in BrisbaneĀ Ā Lab + Life Scientist
Google News
Oct 26, 2026, 4:39 AM
Mankind Pharma Elevates Deepak Sharma to Senior General Manager & Head ā L&D and Recruitment, India & International Business - https://hrtoday.in/
Mankind Pharma Elevates Deepak Sharma to Senior General Manager & Head ā L&D and Recruitment, India & International BusinessĀ Ā https://hrtoday.in/
Google News
Oct 26, 2026, 3:20 AM
The US-China biotech trade war that isnāt - Asia Times
The US-China biotech trade war that isnātĀ Ā Asia Times
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer